YONDELIS Trademark

Trademark Overview

On Friday, January 4, 2002, a trademark application was filed for YONDELIS with the United States Patent and Trademark Office. The USPTO has given the YONDELIS trademark a serial number of 76354944. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 18, 2013. This trademark is owned by PHARMA MAR S.A.. The YONDELIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer for human and veterinary use in all animals
yondelis

General Information

Serial Number76354944
Word MarkYONDELIS
Filing DateFriday, January 4, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 18, 2013
Registration Number3104261
Registration DateTuesday, June 13, 2006
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 24, 2002

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer for human and veterinary use in all animals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 18, 2013
Primary Code005
First Use Anywhere DateThursday, September 8, 2005
First Use In Commerce DateThursday, September 8, 2005

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNEW BRUNSWICK, NJ 089337001
Party NameJOHNSON & JOHNSON
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressNEW BRUNSWICK, NJ 089337001
Party NamePHARMA MAR S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMadrid
ES
Party NamePHARMA MAR S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMadrid
ES

Trademark Events

Event DateEvent Description
Friday, January 18, 2013CANCELLED SEC. 8 (6-YR)
Tuesday, June 13, 2006REGISTERED-PRINCIPAL REGISTER
Wednesday, May 3, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, April 28, 2006ASSIGNED TO LIE
Tuesday, April 18, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 3, 2006STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 15, 2006USE AMENDMENT FILED
Thursday, March 16, 2006PAPER RECEIVED
Saturday, September 24, 2005EXTENSION 5 GRANTED
Sunday, September 18, 2005EXTENSION 5 FILED
Monday, September 19, 2005TEAS EXTENSION RECEIVED
Monday, April 18, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 31, 2005EXTENSION 4 GRANTED
Friday, March 4, 2005EXTENSION 4 FILED
Friday, March 4, 2005TEAS EXTENSION RECEIVED
Thursday, August 19, 2004EXTENSION 3 GRANTED
Friday, August 6, 2004EXTENSION 3 FILED
Monday, August 9, 2004CASE FILE IN TICRS
Friday, August 6, 2004TEAS EXTENSION RECEIVED
Wednesday, March 24, 2004EXTENSION 2 GRANTED
Friday, March 12, 2004EXTENSION 2 FILED
Friday, March 12, 2004PAPER RECEIVED
Wednesday, October 22, 2003EXTENSION 1 GRANTED
Thursday, September 18, 2003EXTENSION 1 FILED
Monday, September 22, 2003PAPER RECEIVED
Tuesday, March 18, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 29, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 24, 2002PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2002NOTICE OF PUBLICATION
Monday, October 21, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 21, 2002ASSIGNED TO EXAMINER
Tuesday, September 3, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 3, 2002PAPER RECEIVED
Friday, May 3, 2002NON-FINAL ACTION MAILED
Thursday, March 28, 2002ASSIGNED TO EXAMINER
Thursday, March 21, 2002ASSIGNED TO EXAMINER

Related Keywords

yondelis veterinary animals human cancer preparations treatment pharmaceutical